🇺🇸 FDA
Pipeline program

Modafinil 200mg

USAARL 2018-007; IRB M-10746

Phase 2 small_molecule active

Quick answer

Modafinil 200mg for Cognition is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Cognition
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials